TAMs are thus responsible for the production of VEGF, of urokinase-type plasminogen activator (uPA), and of matrix metalloproteinase-9 (MMP-9) in human breast carcinomas [46, 48]. The gene discussed is PLAU; the disease is breast carcinoma.